Media Room

As shelter-in-place mandates lessen, societies may be able to reopen parts of their economies while still curbing overall disease spread by limiting interactions related to increased disease.

Study’s findings reveal the challenges humans face and also shed light on new treatment strategies

The ability to detect antibodies against a SARS-CoV-2 infection presents a tremendous opportunity for the development of a COVID-19 diagnostic test.

SARS-CoV-2, the virus that causes COVID-19, uses its spike protein to recognize the receptor ACE2 on human lung cells, attaching the virus to the cells.

Montserrat Torremorell, DVM, PhD, is collaborating with researchers both within the CVM and at the College of Science and Engineering to test whether air purifying systems can inactivate airborne coronaviruses.

Coronaviruses infect humans by binding to specific proteins, known as receptors, on human cell surfaces.

Meggan Craft, PhD, associate professor in the Department of Veterinary Population Medicine is collaborating with Eva Enns, PhD, associate professor in the Division of Health Policy and Management in the School of Public Health, to create a model of how the novel coronavirus moves through an individual’s network.

A team of researchers led by Maxim Cheeran, MVSc, PhD, and Jianping

Proteins of highly pathogenic viruses, such as SARS-CoV-2 that causes COVID-19 disease, play a critical role in the body’s immune response to infection, sometimes causing overt inflammation and tissue damage.

Human pulmonary epithelial cells, which serve many important functions in human lungs, express two key enzymes, ACE2 and TMPRSS2, that help SARS-CoV-2, the virus that causes COVID-19, enter human p